Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edgewise Therapeutics, Inc.

16.40
+0.94006.08%
Pre-market: 15.82-0.5800-3.54%04:11 EDT
Volume:1.22M
Turnover:19.79M
Market Cap:1.72B
PE:-11.33
High:16.54
Open:15.55
Low:14.91
Close:15.46
Loading ...

Earnings Flash (EWTX) Edgewise Therapeutics Posts Q4 Total Operating Expenses $45.5M

MT Newswires Live
·
03 Mar

Earnings Flash (EWTX) Edgewise Therapeutics Posts Q4 Net Loss $0.42 a Share, vs. FactSet Est of $0.37 Loss

MT Newswires Live
·
03 Mar

BRIEF-Edgewise Therapeutics Q4 Basic EPS USD -0.42

Reuters
·
03 Mar

Edgewise Therapeutics Q4 Operating Expenses USD 45.54 Million

THOMSON REUTERS
·
03 Mar

Edgewise Therapeutics Q4 Basic EPS USD -0.42

THOMSON REUTERS
·
03 Mar

Edgewise Therapeutics Q4 Operating Income USD -45.54 Million

THOMSON REUTERS
·
03 Mar

Press Release: Edgewise Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Dow Jones
·
03 Mar

Should You Invest in Edgewise Therapeutics (EWTX)?

Insider Monkey
·
19 Feb

Edgewise placed on ‘Positive Catalyst Watch’ at JPMorgan

TIPRANKS
·
14 Feb

Edgewise Therapeutics Names Behrad Derakhshan as COO; Shares Fall

MT Newswires Live
·
22 Jan

BRIEF-Edgewise Therapeutics Strengthens Leadership Team

Reuters
·
22 Jan

Edgewise Therapeutics Promotes Derakhshan to COO Role

TIPRANKS
·
22 Jan

Edgewise Therapeutics promotes Behrad Derakhshan to COO

TIPRANKS
·
22 Jan

Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development

THOMSON REUTERS
·
22 Jan

Stifel Nicolaus Initiates Coverage on Edgewise Therapeutics With Hold Rating, $30 Price Target

MT Newswires Live
·
22 Jan

Cautious Hold Rating for Edgewise Therapeutics Amid Uncertain Differentiation and Efficacy

TIPRANKS
·
22 Jan

Edgewise Therapeutics initiated with a Hold at Stifel

TIPRANKS
·
22 Jan

Edgewise Therapeutics Insiders Sold US$1.0m Of Shares Suggesting Hesitancy

Simply Wall St.
·
18 Jan

Edgewise Therapeutics: Strategic Positioning and Promising Clinical Advancements Support Buy Rating

TIPRANKS
·
15 Jan

BRIEF-Edgewise Therapeutics Provides Corporate Update And Highlights Priorities For 2025

Reuters
·
13 Jan